Poxel Stock

Poxel Debt 2024

Poxel Debt

30.38 EUR

Ticker

POXEL.PA

ISIN

FR0012432516

WKN

A14M04

In 2024, Poxel's total debt was 30.38 EUR, a 964.84% change from the 2.85 EUR total debt recorded in the previous year.

Poxel Aktienanalyse

What does Poxel do?

Poxel SA is a biopharmaceutical company focused on developing drugs for the treatment of metabolic disorders, particularly type 2 diabetes. The company was founded in Lyon, France, in 2009. Poxel SA's business model is based on the targeted development of drugs for the treatment of metabolic disorders with high medical demand and large market potential. The company focuses on identifying drug candidates that are highly specific and effective while also having a favorable safety profile. Poxel SA collaborates closely with academic research and the industry to leverage the latest knowledge and technologies in drug development. Over the years, Poxel SA has become a leading company in metabolism medicine, with an extensive product pipeline of promising drug candidates. The product range includes both preclinical and clinical candidates, as well as products in advanced stages of clinical development. One of Poxel SA's main products is Imeglimin, a drug for the treatment of type 2 diabetes. Imeglimin is a new active ingredient that acts on the metabolic disorder in a novel way and improves the body's glucose metabolism. The drug is currently in the final phase of clinical development and has shown promising results in previous studies. Another promising product from Poxel SA is PXL770, a drug for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). PXL770 is a novel active ingredient that acts on the body's AMP-activated protein kinase system and regulates lipid and glucose metabolism. The drug is still in the clinical development phase but has already shown promising results. Another promising product group from Poxel SA are the adenosine monophosphate (AMP) activators, which are also being developed for the treatment of metabolic disorders such as type 2 diabetes and fatty liver disease. The AMP activators act on the body's AMP-activated protein kinase system and regulate lipid and glucose metabolism. Poxel SA also works closely with partners in the pharmaceutical industry to develop and bring innovative drug candidates to the market. The company has partnerships with leading companies such as Sumitomo Dainippon Pharma, Roivant Sciences, and Servier to expand and diversify its product pipeline. Overall, Poxel SA is an emerging company in metabolism medicine, focusing on the development of innovative drugs for the treatment of metabolic disorders. With a strong product pipeline and proven collaboration with academia and the industry, Poxel SA is a promising player in this growing market. Poxel ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Poxel's Debt Structure

Poxel's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Poxel's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Poxel’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Poxel’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Poxel stock

What is the debt of Poxel this year?

Poxel has a debt level of 30.38 EUR this year.

What was the debt of Poxel compared to the previous year?

The debt of Poxel has increased by 964.84% compared to the previous year increased.

What are the consequences of high debt for investors in Poxel?

High debt can pose a risk for investors of Poxel, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Poxel?

Low debt means that Poxel has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Poxel affect the company?

An increase in debt of Poxel can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Poxel affect the company?

A reduction in debt of Poxel can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Poxel?

Some factors that can influence the debt of Poxel include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Poxel so important for investors?

The debts of Poxel are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Poxel take to change the debt?

To change the debt, Poxel can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Poxel pay?

Over the past 12 months, Poxel paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Poxel is expected to pay a dividend of 0 EUR.

What is the dividend yield of Poxel?

The current dividend yield of Poxel is .

When does Poxel pay dividends?

Poxel pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Poxel?

Poxel paid dividends every year for the past 0 years.

What is the dividend of Poxel?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Poxel located?

Poxel is assigned to the 'Health' sector.

Wann musste ich die Aktien von Poxel kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Poxel from 10/4/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Poxel pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Poxel in the year 2023?

In the year 2023, Poxel distributed 0 EUR as dividends.

In which currency does Poxel pay out the dividend?

The dividends of Poxel are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Poxel stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Poxel

Our stock analysis for Poxel Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Poxel Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.